share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Watanabe Todd Franklin

SEC announcement ·  Feb 16 07:33
Summary by Futu AI
Todd Franklin Watanabe, associated with Arcutis Biotherapeutics, Inc. [ARQT], reported multiple acquisitions of common stock on February 13, 2024. The transactions, described as grants, awards, or other acquisitions, resulted in a total direct acquisition of 216,882 shares. Following these transactions, Watanabe's direct holdings in the company amounted to 891,901 shares. Additionally, indirect holdings through trusts and an LLC totaled 231,140 shares, with the largest single indirect holding being 124,956 shares by a trust.
Todd Franklin Watanabe, associated with Arcutis Biotherapeutics, Inc. [ARQT], reported multiple acquisitions of common stock on February 13, 2024. The transactions, described as grants, awards, or other acquisitions, resulted in a total direct acquisition of 216,882 shares. Following these transactions, Watanabe's direct holdings in the company amounted to 891,901 shares. Additionally, indirect holdings through trusts and an LLC totaled 231,140 shares, with the largest single indirect holding being 124,956 shares by a trust.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.